Research

How Sticky is Your Blood?

This case-control study will recruit individuals with a diagnosis of MS and healthy controls. Individuals will be asked to come to Bastyr Clinical Research Center for a single study visit, at which time dietary intake, current medications and supplements, other medical diagnoses, and coagulation will be evaluated.

Intranasal Glutathione in Parkinson's Disease

Parkinson's disease (PD) is considered a progressive and irreversible neurodegenerative disease. Current therapies improve disease symptoms, however none alter the underlying degenerative course. Research suggests the loss of brain glutathione, a powerful antioxidant, is one of the earliest changes to occur in the brain of PD patients and the magnitude of glutathione depletion parallels the severity of PD. This study will look at the use of intranasal glutathione in PD patients to determine safety, tolerability, and the impact on PD symptoms.

Systemic iron changes, haptoglobin phenotypes and Parkinson's disease risk

This study explores if changes in serum iron levels and iron binding proteins are associated with an increased risk of developing Parkinson's disease. This study focuses on iron changes due to the presence of particular phenotypes, or lifestyle factors, or the interplay between genetic and environmental factors.

Healthy participants were recruited as well as patients affected with Parkinson's disease, in a case/controls study.

Pending in 2013:
Publications; NIH grant funding to expand the research study.

Sauna Detoxification Study

The primary goal of this study is to conduct a methodologically rigorous investigation of a hyperthermia-based, medically monitored, detoxification protocol in order to assess the impact of sauna use on potential reductions in blood polychlorinated biphenyls (PCB) concentrations.

CAM Therapies in Colon Cancer

Bastyr Integrative Oncolgy Reserch Center (BIORC) is actively recruiting participants with colon cancer at any stage to take part in an observational research study. By studying how cancer reacts when treated with naturopathic medicine, traditional Chinese medicine, acupuncture and mind-body therapies, we hope to uncover complementary and alternative medical (CAM) solutions that help patients fight cancer while also managing the effects of chemotherapy.

Estrogen plus progestin and colorectal cancer in postmenopausal women.

 

BACKGROUND:

Although the Women's Health Initiative (WHI) trial of estrogen plus progestin in postmenopausal women identified more overall health risks than benefits among women in the hormone group, the use of estrogen plus progestin was associated with a significant decrease in the risk of colorectal cancer. We analyzed features of the colorectal cancers that developed and their relation to the characteristics of the participants.